))
Hear how past DES lessons and today’s newest tech are shaping Medtronic’s future coronary strategy
Manage episode 342490749 series 3392811
Innhold levert av MedtronicTalks and Tom Salemi. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av MedtronicTalks and Tom Salemi eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this episode, Jason Fontana, vice president coronary and renal denervation marketing and strategy at Medtronic, will walk us through Medtronic’s successful entry into the drug-eluting stent market over a decade ago with the Endeavor DES, the first modular drug-eluting stent. With a focus on healing and deliverability, Medtronic overcome a late-start to become a leader of the pack following the approval of the Resolute Integrity DES. We’ll review Medtronic’s current coronary portfolio including Onyx Frontier DES with a dual flex balloon. Fontana will also explain how new technologies and diagnostic techniques will help it set the pace in the coronary space in the future. Thanks to Delve for sponsoring! Thank you for listening to the MedtronicTalks Podcast.
…
continue reading
47 episoder
Del
